EVO · Healthcare · $607M
$1.71+4.27%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“에보텍의 핵심 성장 엔진은 'AI 기반 신약 발굴 플랫폼'이에요.”
In the company's words · 2026 1분기 earnings call